http://www.pathway2curis.com/hedgehog-pathway-cancers-clinical-trials.html 2011-06-03T15:32:35+00:00 always 1.0 http://www.pathway2curis.com/ipi-926-vs-gdc-0449-vs-itraconazole-t58.html 2011-06-03T15:32:35+00:00 monthly 0.6 http://www.pathway2curis.com/curis-genentech-inhibitor-gdc-0449-rg3616-t4.html 2011-03-21T15:50:02+00:00 yearly 0.8 http://www.pathway2curis.com/stanford-university-itraconazole-bcc-t53.html 2011-03-12T21:10:59+00:00 yearly 0.5 http://www.pathway2curis.com/vismodegib-basal-cell-nevus-syndrome-t47.html 2011-02-08T03:15:23+00:00 yearly 0.5 http://www.pathway2curis.com/phase-ii-clinical-trial-update-bcc-colon-ovarian-cancers-t7.html 2011-01-29T21:37:15+00:00 yearly 0.5 http://www.pathway2curis.com/millennium-pharmaceuticals-hedgehog-inhibitor-tak-441-t25.html 2010-12-12T00:41:26+00:00 yearly 0.5 http://www.pathway2curis.com/pancreatic-cancer-pii-w-gdc-0449-gemcitabine-abraxane-t22.html 2010-03-18T15:05:15+00:00 yearly 0.3 http://www.pathway2curis.com/notch-hedge-clinical-trials-developmental-pathway-t18.html 2010-03-14T00:21:19+00:00 yearly 0.3 http://www.pathway2curis.com/bristol-myers-squibb-exelixis-hedgehog-inhibitor-bms-83392-t2.html 2010-02-28T01:25:42+00:00 yearly 0.8 http://www.pathway2curis.com/infinity-pharmaceuticals-hedgehog-inhibitor-ipi-926-t8.html 2010-02-28T01:06:52+00:00 yearly 0.8 http://www.pathway2curis.com/novartis-pharmaceuticals-lde225-leq506-hedgehog-inihbitor-t9.html 2010-02-28T00:59:43+00:00 yearly 0.8 http://www.pathway2curis.com/pii-trial-started-of-pancreatic-cancer-and-gdc-0499-t12.html 2010-02-12T01:26:19+00:00 yearly 0.3 http://www.pathway2curis.com/pfizer-hedgehog-clinical-trials-pf-04449913-t3.html 2010-02-08T05:25:06+00:00 yearly 0.8